CSPC Pharmaceutical Group Statistics
Total Valuation
HKG:1093 has a market cap or net worth of HKD 101.03 billion. The enterprise value is 93.50 billion.
Market Cap | 101.03B |
Enterprise Value | 93.50B |
Important Dates
The last earnings date was Friday, May 23, 2025.
Earnings Date | May 23, 2025 |
Ex-Dividend Date | Jun 4, 2025 |
Share Statistics
HKG:1093 has 11.43 billion shares outstanding. The number of shares has decreased by -1.85% in one year.
Current Share Class | 11.43B |
Shares Outstanding | 11.43B |
Shares Change (YoY) | -1.85% |
Shares Change (QoQ) | -1.02% |
Owned by Insiders (%) | 24.97% |
Owned by Institutions (%) | 30.37% |
Float | 7.82B |
Valuation Ratios
The trailing PE ratio is 22.88 and the forward PE ratio is 17.83. HKG:1093's PEG ratio is 2.22.
PE Ratio | 22.88 |
Forward PE | 17.83 |
PS Ratio | 3.48 |
PB Ratio | 2.78 |
P/TBV Ratio | 3.19 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | 2.22 |
Enterprise Valuation
EV / Earnings | 20.80 |
EV / Sales | 3.22 |
EV / EBITDA | 14.33 |
EV / EBIT | 18.18 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.01 |
Debt / EBITDA | 0.08 |
Debt / FCF | n/a |
Interest Coverage | 109.38 |
Financial Efficiency
Return on equity (ROE) is 12.21% and return on invested capital (ROIC) is 8.64%.
Return on Equity (ROE) | 12.21% |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 8.64% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 1.35M |
Profits Per Employee | 210,083 |
Employee Count | 21,400 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, HKG:1093 has paid 1.19 billion in taxes.
Income Tax | 1.19B |
Effective Tax Rate | 20.93% |
Stock Price Statistics
The stock price has increased by +29.99% in the last 52 weeks. The beta is 0.78, so HKG:1093's price volatility has been lower than the market average.
Beta (5Y) | 0.78 |
52-Week Price Change | +29.99% |
50-Day Moving Average | 6.45 |
200-Day Moving Average | 5.42 |
Relative Strength Index (RSI) | 70.06 |
Average Volume (20 Days) | 283,948,724 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1093 had revenue of HKD 28.99 billion and earned 4.50 billion in profits. Earnings per share was 0.39.
Revenue | 28.99B |
Gross Profit | 19.84B |
Operating Income | 5.20B |
Pretax Income | 5.70B |
Net Income | 4.50B |
EBITDA | 6.40B |
EBIT | 5.20B |
Earnings Per Share (EPS) | 0.39 |
Balance Sheet
The company has 9.80 billion in cash and 543.94 million in debt, giving a net cash position of 9.25 billion or 0.81 per share.
Cash & Cash Equivalents | 9.80B |
Total Debt | 543.94M |
Net Cash | 9.25B |
Net Cash Per Share | 0.81 |
Equity (Book Value) | 36.31B |
Book Value Per Share | 3.00 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 68.45%, with operating and profit margins of 17.92% and 15.51%.
Gross Margin | 68.45% |
Operating Margin | 17.92% |
Pretax Margin | 19.66% |
Profit Margin | 15.51% |
EBITDA Margin | 22.09% |
EBIT Margin | 17.92% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.26, which amounts to a dividend yield of 2.87%.
Dividend Per Share | 0.26 |
Dividend Yield | 2.87% |
Dividend Growth (YoY) | -7.14% |
Years of Dividend Growth | 10 |
Payout Ratio | n/a |
Buyback Yield | 1.85% |
Shareholder Yield | 4.79% |
Earnings Yield | 4.45% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on October 15, 2020. It was a forward split with a ratio of 1.6.
Last Split Date | Oct 15, 2020 |
Split Type | Forward |
Split Ratio | 1.6 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |